OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW
Oculis Holding AG
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 4, 2026
$7.32+0.03 (+0.41%)
Close on Oct 19, 2026
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Oculis has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Oculis filed with the SEC
Oculis Announces Resignation of Lionel Carnot from Board of Directors
EX-99.1 to Form 6-K
P7Y P7Y P7Y P7Y P1Y P4Y P3M P6M
EX-99.1 to Form 6-K
Oculis Reports Q2 2026 Financial Results and Provides Company Update
EX-99.3 to Form 6-K
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
OCS-01 Phase 3 DIAMOND Trials Topline Results in DME May 29, 2026
EX-99.2 to Form 6-K
(Translation; in case of controversy the German text shall prevail)
EX-99.2 to Form 6-K
Unaudited Condensed Consolidated Interim Financial Statements
EX-99.1 to Form 6-K
Oculis Reports Q1 2026 Financial Results and Provides Company Update
EX-99.3 to Form 6-K
Oculis Publishes Invitation to the Annual General Meeting
EX-99.1 to Form 6-K
To the Shareholders of Oculis Holding AG, in Zug, SWITZERLAND
EX-99.2 to Form 6-K
EX-99.3 to Form 6-K
EX-99.3 to Form 6-K
Report of the statutory auditor to the General Meeting
EX-99.1 to Form 6-K
for the period ending December 31, 2025
EX-99.2 to Form 6-K
Unaudited Condensed Consolidated Interim Financial Statements
EX-99.1 to Form 6-K
Oculis Reports Q3 2025 Financial Results and Provides Company Update
EX-99.3 to Form 6-K
Registrational Trials in Acute Optic Neuritis,
EX-99.1 to Form 6-K
FDA update October 6th, 2025 Exhibit 99.2
EX-99.2 to Form 6-K
Unaudited Condensed Consolidated Interim Financial Statements
EX-99.1 to Form 6-K
Oculis Reports Q2 2025 Financial Results and Provides Company Update
EX-99.3 to Form 6-K
Oculis Publishes Results of 2025 Annual General Meeting
EX-99.1 to Form 6-K
(Translation; in case of controversy the German text shall prevail)
EX-99.2 to Form 6-K
Oculis Publishes Invitation to the Annual General Meeting
EX-99.1 to Form 6-K
To the Shareholders of Oculis Holding AG, in Zug, SWITZERLAND
EX-99.2 to Form 6-K
EX-99.3 to Form 6-K
EX-99.3 to Form 6-K
Unaudited Condensed Consolidated Interim Financial Statements
EX-99.1 to Form 6-K
Oculis Reports Q1 2025 Financial Results and Provides Company Update
EX-99.3 to Form 6-K
EX-99.1 to Form 6-K
EX-99.1 to Form 6-K
Report of the statutory auditor to the General Meeting
EX-99.2 to Form 6-K